Manufacturing uncertainty: adverse effects of drug development for women.
Peppin
Patricia
P
Associate Professor of Law, Queen's University Faculty of Law, Queen's University, Kingston, Ontario, Canada K7L 3N6. peppinp@qsilver.queensu.ca
D000329:Advertising; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000592:standards; D002170:Canada; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004345:Drug Industry; D004348:Drug Labeling; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D033181:Information Dissemination; D004364:Pharmaceutical Preparations / Q000592:standards; D011247:Pregnancy; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D035501:Uncertainty; D016387:Women's Health
D014150:Antipsychotic Agents; D004364:Pharmaceutical Preparations